# CNS Lymphoma Diagnosis and Treatment
**Type:** Topics
**Canonical URL:** https://scholariq.org/topics/cns-lymphoma-diagnosis-and-treatment/
## Facts
| Field | Value |
| --- | --- |
| Description | This cluster of papers focuses on the diagnosis, treatment, and management of primary central nervous system lymphoma (PCNSL). It covers various aspects such as prognostic scoring systems, chemotherapy and radiotherapy regimens, use of methotrexate and rituximab therapy, genetic features, neurological masquerade syndromes, and cognitive functions in PCNSL patients. |
| Domain | Health Sciences |
| Field | Medicine |
| OpenAlex ID | t12212 |
| Works | 101 |
## Topic papers all
Showing 15 of 101.
- [Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group](https://scholariq.org/papers/role-of-imaging-in-the-staging-and-response-assessment-of-lymphoma-consensus-of/)
- [Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)](https://scholariq.org/papers/revisions-to-the-staging-and-classification-of-mycosis-fungoides-and-sezary/)
- [Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma](https://scholariq.org/papers/rituximab-chop-versus-chop-alone-or-with-maintenance-rituximab-in-older-patients/)
- [Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma](https://scholariq.org/papers/use-of-positron-emission-tomography-for-response-assessment-of-lymphoma/)
- [Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma](https://scholariq.org/papers/tumor-associated-macrophages-and-survival-in-classic-hodgkin-s-lymphoma/)
- [Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project](https://scholariq.org/papers/follicular-lymphoma-international-prognostic-index-2-a-new-prognostic-index-for/)
- [Understanding and Managing Methotrexate Nephrotoxicity](https://scholariq.org/papers/understanding-and-managing-methotrexate-nephrotoxicity/)
- [Anti-LGI1 encephalitis](https://scholariq.org/papers/anti-lgi1-encephalitis/)
- [International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease](https://scholariq.org/papers/international-evidence-based-consensus-diagnostic-criteria-for-hhv-8-negative/)
- [High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial](https://scholariq.org/papers/high-dose-methotrexate-with-or-without-whole-brain-radiotherapy-for-primary-cns/)
- [Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement.](https://scholariq.org/papers/recommended-standard-of-cerebrospinal-fluid-analysis-in-the-diagnosis-of/)
- [Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial](https://scholariq.org/papers/adalimumab-for-prevention-of-uveitic-flare-in-patients-with-inactive-non/)
- [Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma](https://scholariq.org/papers/inhibition-of-b-cell-receptor-signaling-by-ibrutinib-in-primary-cns-lymphoma/)
- [High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell Lymphoma](https://scholariq.org/papers/high-dose-chemotherapy-and-autologous-bone-marrow-transplantation-compared-with/)
- [European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas](https://scholariq.org/papers/european-organization-for-research-and-treatment-of-cancer-and-international/)
## Topic primary papers
Showing 15 of 26.
- [Understanding and Managing Methotrexate Nephrotoxicity](https://scholariq.org/papers/understanding-and-managing-methotrexate-nephrotoxicity/)
- [High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial](https://scholariq.org/papers/high-dose-methotrexate-with-or-without-whole-brain-radiotherapy-for-primary-cns/)
- [Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma](https://scholariq.org/papers/inhibition-of-b-cell-receptor-signaling-by-ibrutinib-in-primary-cns-lymphoma/)
- [Intraocular Lymphoma](https://scholariq.org/papers/intraocular-lymphoma/)
- [Results of Whole-Brain Radiation As Salvage of Methotrexate Failure for Immunocompetent Patients With Primary CNS Lymphoma](https://scholariq.org/papers/results-of-whole-brain-radiation-as-salvage-of-methotrexate-failure-for/)
- [Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas](https://scholariq.org/papers/recurrent-mutations-of-scp-i-cd79b-i-scp-and-scp-i-myd88-i-scp-are-the-hallmark/)
- [CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma](https://scholariq.org/papers/cxcl13-plus-interleukin-10-is-highly-specific-for-the-diagnosis-of-cns-lymphoma/)
- [IL-10 Measurement in Aqueous Humor for Screening Patients with Suspicion of Primary Intraocular Lymphoma](https://scholariq.org/papers/il-10-measurement-in-aqueous-humor-for-screening-patients-with-suspicion-of/)
- [A Systematic Approach to the Diagnosis of Suspected Central Nervous System Lymphoma](https://scholariq.org/papers/a-systematic-approach-to-the-diagnosis-of-suspected-central-nervous-system/)
- [Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network](https://scholariq.org/papers/primary-cns-lymphoma-at-first-relapse-progression-characteristics-management-and/)
- [First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)—a systematic review and individual patient data meta-analysis](https://scholariq.org/papers/first-line-treatment-and-outcome-of-elderly-patients-with-primary-central/)
- [Cognitive functions in primary central nervous system lymphoma: literature review and assessment guidelines](https://scholariq.org/papers/cognitive-functions-in-primary-central-nervous-system-lymphoma-literature-review/)
- [Treatment Strategies in Primary Vitreoretinal Lymphoma](https://scholariq.org/papers/treatment-strategies-in-primary-vitreoretinal-lymphoma/)
- [Cognitive status and quality of life after treatment for primary CNS lymphoma](https://scholariq.org/papers/cognitive-status-and-quality-of-life-after-treatment-for-primary-cns-lymphoma/)
- [Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery](https://scholariq.org/papers/survival-of-aids-patients-with-primary-central-nervous-system-lymphoma-is/)
---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.